Chinese biotech giant WuXi AppTec reports strong US revenue despite Washington scrutiny

INSUBCONTINENT EXCLUSIVE:

The company, which has been targeted by Washington, saw US revenue jump 28 per cent in the first quarter, compared with 21 per cent

globally.